T. Rowe Price Associates’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Sell |
61,114
-683,430
| -92% | -$10.9M | ﹤0.01% | 1998 |
|
|
2025
Q1 | $12.7M | Sell |
744,544
-171,706
| -19% | -$2.93M | ﹤0.01% | 1064 |
|
|
2024
Q4 | $22.7M | Sell |
916,250
-292,796
| -24% | -$7.25M | ﹤0.01% | 964 |
|
|
2024
Q3 | $34.5M | Sell |
1,209,046
-152,603
| -11% | -$4.35M | ﹤0.01% | 857 |
|
|
2024
Q2 | $35.9M | Sell |
1,361,649
-500,394
| -27% | -$13.2M | ﹤0.01% | 816 |
|
|
2024
Q1 | $60.2M | Buy |
1,862,043
+259,481
| +16% | +$8.38M | 0.01% | 678 |
|
|
2023
Q4 | $67.5M | Buy |
1,602,562
+872,520
| +120% | +$36.8M | 0.01% | 620 |
|
|
2023
Q3 | $28M | Buy |
730,042
+710,514
| +3,638% | +$27.3M | ﹤0.01% | 834 |
|
|
2023
Q2 | $371K | Sell |
19,528
-423,676
| -96% | -$8.05M | ﹤0.01% | 2272 |
|
|
2023
Q1 | $6.88M | Buy |
443,204
+167,205
| +61% | +$2.59M | ﹤0.01% | 1118 |
|
|
2022
Q4 | $4.9M | Buy |
+275,999
| New | +$4.9M | ﹤0.01% | 1195 |
|
|
2021
Q4 | – | Sell |
-22,680
| Closed | -$197K | – | 3010 |
|
|
2021
Q3 | $197K | Buy |
22,680
+5,077
| +29% | +$44.1K | ﹤0.01% | 2726 |
|
|
2021
Q2 | $186K | Buy |
17,603
+345
| +2% | +$3.65K | ﹤0.01% | 2738 |
|
|
2021
Q1 | $277K | Sell |
17,258
-272,730
| -94% | -$4.38M | ﹤0.01% | 2586 |
|
|
2020
Q4 | $13.4M | Buy |
289,988
+84,438
| +41% | +$3.9M | ﹤0.01% | 1304 |
|
|
2020
Q3 | $7.23M | Buy |
+205,550
| New | +$7.23M | ﹤0.01% | 1362 |
|